Follow-up of Patients with Thyroid Carcinoma
- 25 September 1997
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (13) , 928-931
- https://doi.org/10.1056/nejm199709253371311
Abstract
There are about 14,000 new cases of thyroid carcinoma in the United States each year, about 90 percent of them differentiated — papillary and follicular — carcinomas, and about 1100 deaths.1 Thus, the number of patients needing follow-up grows, and because the median age at diagnosis is about 40 years and recurrences can occur at any time for several decades, the follow-up will necessarily be long. Furthermore, a recent study from the National Cancer Institute suggests that the number of cases may increase slightly as a result of the ingestion of radioactive iodine produced by atomic-weapons testing in the western . . .Keywords
This publication has 6 references indexed in Scilit:
- Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid CarcinomaNew England Journal of Medicine, 1997
- Thyroid Remnant 131I Ablation for Papillary and Follicular Thyroid CarcinomaThyroid®, 1997
- Prognostic factors for thyroid carcinomaCancer, 1997
- Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancerJournal of Clinical Endocrinology & Metabolism, 1996
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancerJournal of Clinical Endocrinology & Metabolism, 1994